These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8111543)

  • 1. Human dystrophin gene transfer: genetic correction of dystrophin deficiency.
    Dickson G; Dunckley M
    Mol Cell Biol Hum Dis Ser; 1993; 3():283-302. PubMed ID: 8111543
    [No Abstract]   [Full Text] [Related]  

  • 2. The physiological evaluation of gene therapies of dystrophin-deficient muscles.
    Gillis JM; Deconinck N
    Adv Exp Med Biol; 1998; 453():411-6; discussion 417. PubMed ID: 9889852
    [No Abstract]   [Full Text] [Related]  

  • 3. Retroviral-mediated gene transfer into murine and human skeletal muscle for the correction of dystrophin deficiency.
    Fassati A; Serpente P; Wells DJ; Walsh FS; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):275S. PubMed ID: 8736933
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy of Duchenne muscular dystrophy.
    Fassati A; Murphy S; Dickson G
    Adv Genet; 1997; 35():117-53. PubMed ID: 9348647
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of research on the Xp21 myopathies.
    Perry SV
    J Muscle Res Cell Motil; 1992 Jun; 13(3):377-80. PubMed ID: 1356113
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo.
    Dunckley MG; Wells DJ; Walsh FS; Dickson G
    Hum Mol Genet; 1993 Jun; 2(6):717-23. PubMed ID: 8353491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell and gene therapy in Duchenne muscular dystrophy.
    Morgan JE
    Hum Gene Ther; 1994 Feb; 5(2):165-73. PubMed ID: 7514447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral vectors for gene transfer of full-length human dystrophin cDNAs.
    Murphy S; Turner G; Piper T; Roberts B; Wadworth S; Smith AE; Wells DJ; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):277S. PubMed ID: 8736935
    [No Abstract]   [Full Text] [Related]  

  • 9. Utrophin: a potential replacement for dystrophin?
    Tinsley JM; Davies KE
    Neuromuscul Disord; 1993; 3(5-6):537-9. PubMed ID: 8186707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.
    Phelps SF; Hauser MA; Cole NM; Rafael JA; Hinkle RT; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 1995 Aug; 4(8):1251-8. PubMed ID: 7581361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
    Matsumura K; Campbell KP
    Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Backup gene may help muscles help themselves.
    Roush W
    Science; 1997 Apr; 276(5309):35. PubMed ID: 9122707
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of pre-mRNA splicing in the Duchenne muscular dystrophy gene.
    Dunckley MG; Eperon IC; Dickson G
    Biochem Soc Trans; 1996 May; 24(2):276S. PubMed ID: 8736934
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene therapy research for Duchenne and Becker muscular dystrophies.
    Karpati G; Gilbert R; Petrof BJ; Nalbantoglu J
    Curr Opin Neurol; 1997 Oct; 10(5):430-5. PubMed ID: 9330891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy.
    Wells DJ; Wells KE; Asante EA; Turner G; Sunada Y; Campbell KP; Walsh FS; Dickson G
    Hum Mol Genet; 1995 Aug; 4(8):1245-50. PubMed ID: 7581360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of the dystrophic phenotype by germ-line gene therapy with recombinant dystrophin cDNAs in mdx mice.
    Wells DJ; Dickson G; Wells KE
    Biochem Soc Trans; 1996 May; 24(2):279S. PubMed ID: 8736937
    [No Abstract]   [Full Text] [Related]  

  • 17. CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci.
    Kapsa RM; Wong SH; Bertoncello I; Quigley AF; Williams B; Sells K; Marotta R; Kita M; Simmons P; Byrne E; Kornberg AJ
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S61-6. PubMed ID: 12206798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts.
    Trivedi RA; Dickson G
    J Neurochem; 1995 May; 64(5):2230-8. PubMed ID: 7722508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lessons of dystrophin].
    Desnuelle C
    Presse Med; 1994 May; 23(19):896-900. PubMed ID: 7937619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide-mediated gene therapy for muscular dystrophies.
    Rando TA
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S55-60. PubMed ID: 12206797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.